{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:35:04Z","timestamp":1648708504048},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00120-017-0358-8","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T13:43:41Z","timestamp":1490017421000},"page":"624-626","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Operative Therapie von Metastasen beim Peniskarzinom \u2013 gibt es eine wissenschaftliche Grundlage?"],"prefix":"10.1007","volume":"56","author":[{"given":"O. W.","family":"Hakenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Protzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"issue":"1","key":"358_CR1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg OW et\u00a0al (2015) EAU guidelines on penile cancer: 2014 update. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"key":"358_CR2","first-page":"18","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumours. Wiley Blackwell, Oxford, S\u00a018\u2013190"},{"issue":"6","key":"358_CR3","first-page":"679","volume":"87","author":"EH Daseler","year":"1948","unstructured":"Daseler EH, Anson BJ, Reimann AF (1948) Radical excision of the inguinal and iliac lymph glands; a\u00a0study based upon 450 anatomical dissections and upon supportive clinical observations. Surg Gynecol Obstet 87(6):679\u2013694","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"358_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/end.2012.0489","volume":"27","author":"C Schwentner","year":"2013","unstructured":"Schwentner C et al (2013) Endoscopic inguinofemoral lymphadenectomy \u2013 extended follow-up. J\u00a0Endourol 27(4):497\u2013503","journal-title":"J Endourol"},{"issue":"4","key":"358_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","volume":"191","author":"G Lughezzani","year":"2014","unstructured":"Lughezzani G et\u00a0al (2014) The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a\u00a0single institution experience. J\u00a0Urol 191(4):977\u2013982","journal-title":"J Urol"},{"issue":"6","key":"358_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/02841868809094366","volume":"27","author":"G Pizzocaro","year":"1988","unstructured":"Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6):823\u2013824","journal-title":"Acta Oncol"},{"issue":"11","key":"358_CR7","doi-asserted-by":"publisher","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","volume":"33","author":"P Sharma","year":"2015","unstructured":"Sharma P et al (2015) Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a\u00a0multi-institutional study. Urol Oncol 33(11):496.e17\u2013496.e23","journal-title":"Urol Oncol"},{"issue":"2 Suppl 1","key":"358_CR8","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.urology.2010.03.082","volume":"76","author":"CA Pettaway","year":"2010","unstructured":"Pettaway CA et\u00a0al (2010) Tretament of visceral, unresectable or bulky\/unresectable regional metastases of penile cancer. Urology 76(2 Suppl 1):S58\u2013S65","journal-title":"Urology"},{"issue":"2","key":"358_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000475360","volume":"26","author":"JN Kulkarni","year":"1994","unstructured":"Kulkarni JN, Kamat MR (1994) Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2 A carcinoma of the penis. Eur Urol 26(2):123\u2013128","journal-title":"Eur Urol"},{"issue":"2","key":"358_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","volume":"186","author":"KN Franks","year":"2011","unstructured":"Franks KN et\u00a0al (2011) Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals. J\u00a0Urol 186(2):524\u2013529","journal-title":"J Urol"},{"issue":"1","key":"358_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.08.013","volume":"88","author":"LM Burt","year":"2014","unstructured":"Burt LM, Shrieve DC, Tward JD (2014) Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys 88(1):94\u2013100","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"358_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000176016","volume":"82","author":"C Protzel","year":"2009","unstructured":"Protzel C, Hakenberg OW (2009) Chemotherapy in patients with penile carcinoma. Urol Int 82(1):1\u20137","journal-title":"Urol Int"},{"issue":"3","key":"358_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","volume":"55","author":"G Pizzocaro","year":"2009","unstructured":"Pizzocaro G, Nicolai N, Milani A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3):546\u2013551","journal-title":"Eur Urol"},{"issue":"6","key":"358_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","volume":"98","author":"OW Hakenberg","year":"2006","unstructured":"Hakenberg OW et\u00a0al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6):1225\u20131227","journal-title":"BJU Int"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-017-0358-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-017-0358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:13:33Z","timestamp":1568938413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-017-0358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s00120-017-0358-8","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]}}}